{"pmcid": "PMC5508045", "pmid": "28550460", "article_title": "The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients", "variants": ["rs9923231", "rs887829", "rs2108622", "rs1057910"], "raw_variants": [["rs9923231"], ["rs1057910"], ["rs2108622"], ["rs887829"]]}
{"pmcid": "PMC4916189", "pmid": "26715213", "article_title": "Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Nai\u0308ve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study", "variants": ["rs3745274", "rs2472677", "CYP2B6*1", "CYP2B6*9", "rs4803419", "rs1045642", "rs28399499"], "raw_variants": [["CYP2B6*1", "CYP2B6*9"], ["rs3745274"], ["rs2472677"], ["rs3745274"], ["rs1045642"], ["rs28399499"], ["rs4803419"]]}
{"pmcid": "PMC12036300", "pmid": "40295977", "article_title": "The frequencies of CYP2C19*2, *3, and *17 alleles and their impact on the clinical efficacy of doubled maintenance dose of clopidogrel in Syrian patients with coronary artery disease", "variants": ["CYP2C19*1", "CYP2C19*2", "CYP2C19*17"], "raw_variants": [["CYP2C19*1", "CYP2C19*2", "CYP2C19*17"], ["CYP2C19*1", "CYP2C19*2", "CYP2C19*17"]]}
{"pmcid": "PMC554812", "pmid": "15743917", "article_title": "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol", "variants": ["HLA-DRB1*03:01", "HLA-B*58:01", "HLA-A*33:03", "rs1594", "HLA-C*03:02"], "raw_variants": [["HLA-B*58:01"], ["HLA-DRB1*03:01"], ["HLA-C*03:02"], ["HLA-A*33:03"], ["rs1594"]]}
{"pmcid": "PMC5561238", "pmid": "28819312", "article_title": "Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles", "variants": ["HLA-B*56:01", "HLA-B*39:10", "HLA-B*55:02", "HLA-B*54:01", "HLA-B*67:01", "HLA-B*15:35", "HLA-B*57:01", "HLA-B*38:01", "HLA-B*39:05", "HLA-B*15:25", "rs3745274", "HLA-B*55:01", "HLA-B*13:02", "HLA-DRB1*04:04", "HLA-B*78:01", "HLA-B*15:01", "HLA-B*35:05", "HLA-C*18:01", "HLA-B*51:02", "HLA-DRB1*01:01", "HLA-B*38:02", "HLA-B*15:12", "HLA-B*35:10", "HLA-C*05:01", "HLA-DRB1*08:01", "HLA-B*52:01", "HLA-B*15:32", "HLA-B*15:24", "HLA-C*04:01", "HLA-B*39:09", "HLA-C*05:09", "HLA-B*56:06", "HLA-B*15:27", "HLA-DRB1*01:03", "HLA-DRB1*01:02", "HLA-C*04:07", "HLA-C*04:03", "HLA-B*39:06", "rs28399499", "HLA-DRB1*10:01", "HLA-C*04:06", "HLA-B*39:01", "HLA-B*51:01"], "raw_variants": [["HLA-B*67:01"], ["HLA-B*78:01"], ["HLA-B*51:02"], ["HLA-B*56:06"], ["HLA-B*39:01"], ["HLA-C*05:09"], ["HLA-B*15:32"], ["HLA-C*05:01"], ["HLA-B*51:01"], ["HLA-B*15:35"], ["HLA-B*15:12"], ["HLA-DRB1*08:01"], ["HLA-B*39:10"], ["HLA-B*38:02"], ["HLA-B*38:01"], ["HLA-DRB1*04:04"], ["HLA-B*56:01"], ["HLA-B*35:05"], ["HLA-DRB1*01:02"], ["HLA-B*39:09"], ["HLA-B*15:01"], ["HLA-B*15:27"], ["HLA-B*35:10"], ["HLA-C*04:06"], ["HLA-B*57:01"], ["HLA-C*04:07"], ["HLA-B*55:02"], ["HLA-DRB1*01:03"], ["HLA-B*55:01"], ["HLA-B*13:02"], ["HLA-B*15:25"], ["HLA-B*39:06"], ["HLA-C*04:03"], ["HLA-B*54:01"], ["HLA-DRB1*01:01"], ["HLA-B*52:01"], ["HLA-DRB1*10:01"], ["HLA-C*04:01"], ["HLA-B*39:05"], ["HLA-C*18:01"], ["HLA-B*15:24"], ["rs28399499"], ["rs3745274"]]}
{"pmcid": "PMC10946077", "pmid": "38497131", "article_title": "Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1*6 Genotyping in Gastric Cancer", "variants": ["UGT1A1*1", "UGT1A1*6", "UGT1A1*1", "UGT1A1*28", "UGT1A1*1", "UGT1A1*6", "UGT1A1*28"], "raw_variants": [["UGT1A1*1", "UGT1A1*6", "UGT1A1*28"], ["UGT1A1*1", "UGT1A1*28"], ["UGT1A1*1", "UGT1A1*6"]]}
{"pmcid": "PMC6465603", "pmid": "31024313", "article_title": "NUDT15 Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis", "variants": ["rs1142345", "rs116855232"], "raw_variants": [["rs1142345"], ["rs116855232"]]}
{"pmcid": "PMC12038368", "pmid": "40297930", "article_title": "Impacts of Pharmacokinetic Gene Polymorphisms on Steady\u2010State Plasma Concentrations of Simvastatin in Thai Population", "variants": ["rs2306283", "rs4149056"], "raw_variants": [["rs4149056"], ["rs2306283"]]}
{"pmcid": "PMC10880264", "pmid": "38377518", "article_title": "Pharmacogenetic Factors Influence Escitalopram Pharmacokinetics and Adverse Events in Youth with a Family History of Bipolar Disorder: A Preliminary Study", "variants": ["CYP2D6 poor metabolizer", "rs6311", "CYP2C19 intermediate metabolizer"], "raw_variants": [["CYP2C19 intermediate metabolizer"], ["CYP2D6 poor metabolizer"], ["CYP2C19 intermediate metabolizer"], ["rs6311"]]}
{"pmcid": "PMC12331468", "pmid": "40786508", "article_title": "Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer", "variants": ["rs1695", "rs1801265", "rs11280056", "rs45445694"], "raw_variants": [["rs1801265"], ["rs1695"], ["rs11280056"], ["rs45445694"], ["rs1695"]]}
{"pmcid": "PMC6435416", "pmid": "30661084", "article_title": "CYP2D6 genotype and adverse events to risperidone in children and adolescents", "variants": ["CYP2D6*1", "CYP2D6*1xN", "CYP2D6*2", "CYP2D6*2xN", "CYP2D6*3", "CYP2D6*4", "CYP2D6*4xN", "CYP2D6*5", "CYP2D6*6", "CYP2D6*9", "CYP2D6*10", "CYP2D6*17", "CYP2D6*29", "CYP2D6*35", "CYP2D6*41"], "raw_variants": [["CYP2D6*1", "CYP2D6*1xN", "CYP2D6*2", "CYP2D6*2xN", "CYP2D6*3", "CYP2D6*4", "CYP2D6*4xN", "CYP2D6*5", "CYP2D6*6", "CYP2D6*9", "CYP2D6*10", "CYP2D6*17", "CYP2D6*29", "CYP2D6*35", "CYP2D6*41"]]}
{"pmcid": "PMC12319246", "pmid": "40761554", "article_title": "Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort", "variants": ["rs3745274", "rs776746", "rs2273697", "rs2306283", "rs9282564", "rs4244285", "rs2740574", "rs4149056"], "raw_variants": [["rs2740574"], ["rs3745274"], ["rs2306283"], ["rs9282564"], ["rs2273697"], ["rs776746"], ["rs4149056"], ["rs4244285"]]}
{"pmcid": "PMC3548984", "pmid": "23213055", "article_title": "CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8", "variants": ["CYP2D6*1", "CYP2D6*3", "CYP2D6*4", "CYP2D6*6", "CYP2D6*1", "CYP2D6*10", "CYP2D6*41", "CYP2D6*1", "CYP2D6*3", "CYP2D6*4"], "raw_variants": [["CYP2D6*1", "CYP2D6*3", "CYP2D6*4"], ["CYP2D6*1", "CYP2D6*3", "CYP2D6*4", "CYP2D6*6"], ["CYP2D6*1", "CYP2D6*10", "CYP2D6*41"]]}
{"pmcid": "PMC10275785", "pmid": "37332933", "article_title": "Effect of NLRP3 inflammasome genes polymorphism on disease susceptibility and response to TNF-\u03b1 inhibitors in Iraqi patients with rheumatoid arthritis", "variants": ["rs2043211", "rs4612666"], "raw_variants": [["rs2043211"], ["rs4612666"]]}
{"pmcid": "PMC11971672", "pmid": "40184070", "article_title": "Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke: A Nonrandomized Clinical Trial", "variants": ["CYP2C19*1", "CYP2C19*2", "CYP2C19*3", "CYP2C19*17"], "raw_variants": [["CYP2C19*1", "CYP2C19*2", "CYP2C19*3", "CYP2C19*17"]]}
{"pmcid": "PMC11430164", "pmid": "39346054", "article_title": "The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population", "variants": ["CYP3A4*1", "CYP3A4*2", "CYP3A4*3", "CYP3A4*4", "CYP3A4*5", "CYP3A4*9", "CYP3A4*14", "CYP3A4*15", "CYP3A4*16", "CYP3A4*17", "CYP3A4*19", "CYP3A4*24", "CYP3A4*28", "CYP3A4*29", "CYP3A4*31", "CYP3A4*1", "CYP3A4*11", "CYP3A4*18", "CYP3A4*33"], "raw_variants": [["CYP3A4*1", "CYP3A4*2", "CYP3A4*3", "CYP3A4*4", "CYP3A4*5", "CYP3A4*9", "CYP3A4*14", "CYP3A4*15", "CYP3A4*16", "CYP3A4*17", "CYP3A4*19", "CYP3A4*24", "CYP3A4*28", "CYP3A4*29", "CYP3A4*31"], ["CYP3A4*1", "CYP3A4*11", "CYP3A4*18", "CYP3A4*33"]]}
{"pmcid": "PMC8790808", "pmid": "33768542", "article_title": "Class II HLA Variants Associate with Risk of Pegaspargase Hypersensitivity", "variants": ["HLA-DQB1*02:02", "HLA-DQA1*02:01", "rs9958628", "HLA-DRB1*07:01"], "raw_variants": [["HLA-DQA1*02:01"], ["HLA-DQB1*02:02"], ["HLA-DRB1*07:01"], ["rs9958628"]]}
{"pmcid": "PMC11062152", "pmid": "38707740", "article_title": "Risk Factors for Adverse Events of Nanoliposomal Irinotecan Plus 5-Fluorouracil and L-leucovorin", "variants": ["UGT1A1*1", "UGT1A1*6", "UGT1A1*28"], "raw_variants": [["UGT1A1*1", "UGT1A1*6", "UGT1A1*28"], ["UGT1A1*1", "UGT1A1*6", "UGT1A1*28"]]}
{"pmcid": "PMC3839910", "pmid": "23588310", "article_title": "HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children", "variants": ["HLA-B*15:02", "HLA-A*31:01"], "raw_variants": [["HLA-B*15:02"], ["HLA-B*15:02"], ["HLA-A*31:01"], ["HLA-A*31:01"], ["HLA-A*31:01"], ["HLA-B*15:02"]]}
{"pmcid": "PMC3113609", "pmid": "21428769", "article_title": "HLA-A\u26053101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans", "variants": ["HLA-A*31:01"], "raw_variants": [["HLA-A*31:01"], ["HLA-A*31:01"], ["HLA-A*31:01"]]}
{"pmcid": "PMC10786722", "pmid": "38216550", "article_title": "Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity", "variants": ["rs56038477", "rs1801160", "rs2297595"], "raw_variants": [["rs56038477"], ["rs1801160"], ["rs2297595"]]}
{"pmcid": "PMC384715", "pmid": "15024131", "article_title": "Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant", "variants": ["HLA-B*57:01"], "raw_variants": [["HLA-B*57:01"]]}
{"pmcid": "PMC3584248", "pmid": "23476897", "article_title": "CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer", "variants": ["CYP2D6*1", "CYP2D6*2", "CYP2D6*5", "CYP2D6*10", "CYP2D6*41"], "raw_variants": [["CYP2D6*1", "CYP2D6*2", "CYP2D6*5", "CYP2D6*10", "CYP2D6*41"], ["CYP2D6*1", "CYP2D6*2", "CYP2D6*5", "CYP2D6*10", "CYP2D6*41"]]}
{"pmcid": "PMC12035587", "pmid": "40099566", "article_title": "Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency", "variants": ["NUDT15*3"], "raw_variants": [["NUDT15*3"]]}
{"pmcid": "PMC10993165", "pmid": "38568509", "article_title": "Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole-Induced Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis", "variants": ["HLA-B*15:02", "HLA-B*13:01", "HLA-B*38:02"], "raw_variants": [["HLA-B*15:02"], ["HLA-B*13:01"], ["HLA-B*38:02"]]}
{"pmcid": "PMC10399933", "pmid": "37490620", "article_title": "Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants", "variants": ["rs2231142", "CYP2C9*1", "CYP2C9*2", "CYP2C9*3", "rs4149056"], "raw_variants": [["CYP2C9*1", "CYP2C9*2", "CYP2C9*3"], ["rs4149056"], ["rs2231142"], ["rs4149056"], ["rs4149056"]]}
{"pmcid": "PMC4706412", "pmid": "26745506", "article_title": "A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics", "variants": ["CYP4F2*1", "CYP4F2*3", "rs9923231", "rs1800566", "CYP2C9*1", "CYP2C9*2", "CYP2C9*3", "CYP2C9*8"], "raw_variants": [["CYP4F2*1", "CYP4F2*3"], ["CYP2C9*1", "CYP2C9*2", "CYP2C9*3", "CYP2C9*8"], ["rs9923231"], ["rs1800566"]]}
{"pmcid": "PMC6714829", "pmid": "30336686", "article_title": "Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia", "variants": ["rs2306283", "rs4149056"], "raw_variants": [["rs4149056"], ["rs2306283"]]}
{"pmcid": "PMC2859392", "pmid": "20338069", "article_title": "Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults", "variants": ["rs3745274"], "raw_variants": [["rs3745274"], ["rs3745274"]]}
{"pmcid": "PMC11603346", "pmid": "39604537", "article_title": "Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis", "variants": ["CYP2B6*1", "CYP2B6*6"], "raw_variants": [["CYP2B6*1", "CYP2B6*6"], ["CYP2B6*1", "CYP2B6*6"]]}
{"pmcid": "PMC8973308", "pmid": "35431360", "article_title": "Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia", "variants": ["rs1800462", "rs1800460", "rs116855232"], "raw_variants": [["rs116855232"], ["rs1800460"], ["rs1800462"]]}
{"pmcid": "PMC3387531", "pmid": "21505298", "article_title": "Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent", "variants": ["HLA-DRB1*01:01", "rs3745274", "HLA-B*35:01", "rs2054675", "HLA-C*04:01", "rs3786547"], "raw_variants": [["HLA-B*35:01"], ["HLA-DRB1*01:01"], ["HLA-C*04:01"], ["rs3745274"], ["rs2054675"], ["rs3786547"]]}
